Mehrdad Hefazi

T Cell Engineering, Mayo Clinic

Research Area

Biography

Mehrdad Hefazi has not added Biography.
If you are Mehrdad Hefazi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2022

Other Publications

Article	Year
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities. Leukemia research\| PubMed ID: 26410460	2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoi... Transfusion\| PubMed ID: 26446051	2016
Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 27164061	2016
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in pa... Transplant infectious disease : an official journal of the Transplantation Society\| PubMed ID: 27642723	2016
Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 28495641	2017
Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospecti... Mayo Clinic proceedings\| PubMed ID: 29101931	2017
Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes. Bone marrow transplantation\| PubMed ID: 29410547	2018
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 29679771	2018
Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia. Current hematologic malignancy reports\| PubMed ID: 29948644	2018
Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients. Leukemia research\| PubMed ID: 30055376	2018
The association of de novo anti-HLA-DPB1 donor-specific antibody formation and primary graft failure after allogeneic hematopoietic cell transplantation. Human immunology\| PubMed ID: 30142360	2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood\| PubMed ID: 30463995	2019
Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 30772513	2019
Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 31170029	2019
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia. Blood and lymphatic cancer : targets and therapy\| PubMed ID: 31360093	2018
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 32291234	2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab. Blood advances\| PubMed ID: 32453836	2020
Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Bone marrow transplantation\| PubMed ID: 32772045	2021
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia. Blood advances\| PubMed ID: 33152058	2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent ther... Cancer\| PubMed ID: 33259056	2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 33388419	2021
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies. Leukemia & lymphoma\| PubMed ID: 33682608	2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-wo... Bone marrow transplantation\| PubMed ID: 33824440	2021
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity. Cancer immunology research\| PubMed ID: 34244299	2021
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis. British journal of haematology\| PubMed ID: 34254289	2021
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges. International journal of molecular sciences\| PubMed ID: 34575843	2021
Emerging approaches to improve allogeneic hematopoietic cell transplantation outcomes for non-malignant diseases. Blood\| PubMed ID: 34614174	2021
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction. Blood cancer journal\| PubMed ID: 34802042	2021
Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma. Blood\| PubMed ID: 35090171	2022